BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32443455)

  • 21. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways.
    Mohinta S; Kannan AK; Gowda K; Amin SG; Perdew GH; August A
    Toxicol Sci; 2015 Jun; 145(2):233-43. PubMed ID: 25716673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.
    Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF
    Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.
    Reiners JJ; Clift R; Mathieu P
    Carcinogenesis; 1999 Aug; 20(8):1561-6. PubMed ID: 10426807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells.
    Brantley E; Patel V; Stinson SF; Trapani V; Hose CD; Ciolino HP; Yeh GC; Gutkind JS; Sausville EA; Loaiza-Pérez AI
    Anticancer Drugs; 2005 Feb; 16(2):137-43. PubMed ID: 15655410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
    Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
    Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells.
    Piwarski SA; Thompson C; Chaudhry AR; Denvir J; Primerano DA; Fan J; Salisbury TB
    Biochem Pharmacol; 2020 Apr; 174():113845. PubMed ID: 32032581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
    O'Donnell EF; Jang HS; Liefwalker DF; Kerkvliet NI; Kolluri SK
    Apoptosis; 2021 Jun; 26(5-6):307-322. PubMed ID: 33893898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin-6-C-β-D-glucopyranoside, natural analog of quercetin exhibits anti-prostate cancer activity by inhibiting Akt-mTOR pathway via aryl hydrocarbon receptor.
    Hamidullah ; Kumar R; Saini KS; Kumar A; Kumar S; Ramakrishna E; Maurya R; Konwar R; Chattopadhyay N
    Biochimie; 2015 Dec; 119():68-79. PubMed ID: 26476001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
    McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
    Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
    Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
    PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T.
    Kamenickova A; Anzenbacherova E; Pavek P; Soshilov AA; Denison MS; Anzenbacher P; Dvorak Z
    Toxicol Lett; 2013 Apr; 218(3):253-9. PubMed ID: 23419638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.
    Loaiza-Pérez AI; Trapani V; Hose C; Singh SS; Trepel JB; Stevens MF; Bradshaw TD; Sausville EA
    Mol Pharmacol; 2002 Jan; 61(1):13-9. PubMed ID: 11752201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.
    Henseler RA; Romer EJ; Sulentic CE
    Toxicology; 2009 Jun; 261(1-2):9-18. PubMed ID: 19447539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive modeling of aryl hydrocarbon receptor (AhR) agonism.
    Goya-Jorge E; Giner RM; Sylla-Iyarreta Veitía M; Gozalbes R; Barigye SJ
    Chemosphere; 2020 Oct; 256():127068. PubMed ID: 32447110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?
    Bradshaw TD; Trapani V; Vasselin DA; Westwell AD
    Curr Pharm Des; 2002; 8(27):2475-90. PubMed ID: 12369945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey.
    Hanieh H; Bani Ismail M; Alfwuaires MA; Ibrahim HM; Farhan M
    Molecules; 2023 May; 28(10):. PubMed ID: 37241719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
    Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
    Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB.
    Zhang S; Patel A; Chu C; Jiang W; Wang L; Welty SE; Moorthy B; Shivanna B
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):92-101. PubMed ID: 25831079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes.
    Zhu J; Singh M; Selivanova G; Peuget S
    Sci Rep; 2020 Jan; 10(1):1049. PubMed ID: 31974452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.